B.W. Karlson

753 total citations
25 papers, 578 citations indexed

About

B.W. Karlson is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, B.W. Karlson has authored 25 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in B.W. Karlson's work include Acute Myocardial Infarction Research (11 papers), Cardiac Imaging and Diagnostics (6 papers) and Heart Failure Treatment and Management (5 papers). B.W. Karlson is often cited by papers focused on Acute Myocardial Infarction Research (11 papers), Cardiac Imaging and Diagnostics (6 papers) and Heart Failure Treatment and Management (5 papers). B.W. Karlson collaborates with scholars based in Sweden, Australia and United Kingdom. B.W. Karlson's co-authors include Johan Herlitz, Åke Hjalmarson, A Bengtson, Eva Brink, Lillemor R.‐M. Hallberg, Pontus Pettersson, S. Johansson, Ingela Wiklund, Marianne Hartford and Nils Edvardsson and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

B.W. Karlson

24 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.W. Karlson Sweden 14 353 91 84 83 79 25 578
Antônio Carlos C. Carvalho Brazil 15 327 0.9× 104 1.1× 66 0.8× 117 1.4× 40 0.5× 42 571
José Augusto Barreto‐Filho Brazil 12 295 0.8× 64 0.7× 79 0.9× 116 1.4× 14 0.2× 26 611
A.J. Mourant United Kingdom 7 269 0.8× 41 0.5× 19 0.2× 136 1.6× 67 0.8× 11 448
Märit Mejhert Sweden 17 651 1.8× 51 0.6× 17 0.2× 63 0.8× 52 0.7× 22 800
Lena Mathews United States 13 265 0.8× 28 0.3× 31 0.4× 69 0.8× 32 0.4× 40 511
Darryl McGill Australia 17 435 1.2× 88 1.0× 26 0.3× 129 1.6× 125 1.6× 27 715
Claude Lauzon Canada 13 605 1.7× 34 0.4× 139 1.7× 119 1.4× 137 1.7× 25 812
Arto Pietilä Finland 13 292 0.8× 56 0.6× 60 0.7× 89 1.1× 27 0.3× 34 558
Fabienne Witassek Switzerland 12 222 0.6× 45 0.5× 55 0.7× 35 0.4× 50 0.6× 24 446
C. Moreno Spain 11 280 0.8× 36 0.4× 47 0.6× 357 4.3× 14 0.2× 21 618

Countries citing papers authored by B.W. Karlson

Since Specialization
Citations

This map shows the geographic impact of B.W. Karlson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.W. Karlson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.W. Karlson more than expected).

Fields of papers citing papers by B.W. Karlson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.W. Karlson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.W. Karlson. The network helps show where B.W. Karlson may publish in the future.

Co-authorship network of co-authors of B.W. Karlson

This figure shows the co-authorship network connecting the top 25 collaborators of B.W. Karlson. A scholar is included among the top collaborators of B.W. Karlson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.W. Karlson. B.W. Karlson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Xin, Markus Karlsson, Yawei Xu, et al.. (2017). GW28-e0740 eHelp China, a randomised trial evaluating the effect of a smart phone-based patient support tool on treatment duration in patients prescribed rosuvastatin in China. Journal of the American College of Cardiology. 70(16). C27–C28. 1 indexed citations
2.
Palmer, M K, Stephen J. Nicholls, Pia Lundman, Philip J. Barter, & B.W. Karlson. (2015). Estimating the reduction in 10-year atherosclerotic cardiovascular disease risk with statin therapy: A VOYAGER meta-analysis. Atherosclerosis. 241(1). e21–e22. 1 indexed citations
3.
Karlson, B.W., M.K. Palmer, Stephen J. Nicholls, Pia Lundman, & Philip J. Barter. (2014). Attainment of the anticipated >=50% reduction in LDL-C in the four ACC/AHA guidelines statin benefit groups: A voyager meta-analysis. Atherosclerosis. 235(2). e11–e12. 1 indexed citations
4.
Karlson, B.W., Philip J. Barter, M.K. Palmer, Pia Lundman, & Stephen J. Nicholls. (2012). Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: Results from VOYAGER. Nutrition Metabolism and Cardiovascular Diseases. 22(9). 697–703. 13 indexed citations
5.
Herlitz, Johan, et al.. (2005). Factors associated with development of stroke long‐term after myocardial infarction: experiences from the LoWASA trial. Journal of Internal Medicine. 257(2). 201–207. 14 indexed citations
7.
Karlson, B.W., et al.. (2000). Patients admitted to the emergency department with acute chest pain—is there a difference between patients in an urban and a rural area?. European Journal of Emergency Medicine. 7(4). 277–286. 3 indexed citations
8.
Herlitz, Johan, Maria Haglid, Marianne Hartford, et al.. (1998). Risk Indicators for Cerebrovascular Complications After Coronary Artery Bypass Grafting. The Thoracic and Cardiovascular Surgeon. 46(1). 20–24. 15 indexed citations
9.
Blohm, Martin, Marianne Hartford, B.W. Karlson, Thomas Karlsson, & Johan Herlitz. (1994). A media campaign aiming at reducing delay times and increasing the use of ambulance in AMI. The American Journal of Emergency Medicine. 12(3). 315–318. 37 indexed citations
10.
Wiklund, Ingela, et al.. (1993). Subjective symptoms and well-being differ in women and men after myocardial infarction. European Heart Journal. 14(10). 1315–1319. 92 indexed citations
11.
Karlson, B.W., et al.. (1991). Patients admitted to the emergency room with symptoms indicative of acute myocardial infarction. Journal of Internal Medicine. 230(3). 251–258. 80 indexed citations
12.
Hartford, Marianne, Mikael Dellborg, Nils Edvardsson, et al.. (1991). Effects on chest pain of early thrombolytic treatment in suspected acute myocardial infarction: results from the TEAHAT Study.. PubMed. 734. 27–34. 4 indexed citations
13.
Herlitz, Johan, B.W. Karlson, & Åke Hjalmarson. (1990). Mortality and morbidity during one year of follow‐up in suspected acute myocardial infarction in relation to early diagnosis: experiences from the MIAMI trial. Journal of Internal Medicine. 228(2). 125–131. 11 indexed citations
14.
Karlson, B.W., Johan Herlitz, Nils Edvardsson, & S. Bertil Olsson. (1990). Prophylactic treatment after electroconversion of atrial fibrillation. Clinical Cardiology. 13(4). 279–286. 18 indexed citations
15.
Karlson, B.W., et al.. (1990). Eligibility for intravenous thrombolysis in suspected acute myocardial infarction.. Circulation. 82(4). 1140–1146. 35 indexed citations
17.
Herlitz, Johan, et al.. (1988). 5-Year Mortality Rate in Patients with Suspected Acute Myocardial Infarction in Relation to Early Diagnosis. Cardiology. 75(4). 250–259. 20 indexed citations
18.
Herlitz, Johan, et al.. (1988). Morbidity during five years after myocardial infarction and its relation to infarct size. Clinical Cardiology. 11(10). 672–677. 10 indexed citations
19.
Herlitz, Johan, et al.. (1988). Long‐Term morbidity in patients where the initial suspicion of myocardial infarction was not confirmed. Clinical Cardiology. 11(4). 209–214. 13 indexed citations
20.
Karlson, B.W. & Robert J. Henning. (1987). Comparison of nitroglycerin‐tts and long‐acting nitroglycerin tablets in the treatment of angina pectoris: A double‐blind controlled study. Clinical Cardiology. 10(10). 573–577. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026